Ligand Pharmaceuticals Inc (LGND)

Change in Working Capital

-$2.44M

TTM · Period ending: · USD

LGND logo

LGND Change in Working Capital

Latest reported-$2.44M
LGND TTM Change in Working Capital ($3.20M → -$2.44M)
High-resolution chart · PNG

LGND change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
-2,442,000
-1,612,000
-12,665,000
-10,352,000
-370,000
-1,809,000
11,602,000
-15,991,000
-36,190,000
-34,056,000
-34,402,000
8,161,000
34,004,000
24,783,000
65,677,000
25,100,000
6,283,000
6,967,000
-57,004,000
-65,455,000
-49,490,000
-36,997,000
-20,504,000
-38,530,000
-67,712,000
-137,316,000
-4,215,000
-1,155,000
12,161,000
79,544,000
-38,854,000
-11,619,000
5,624,000
-650,000
-11,438,000
-7,444,000
-5,533,000
3,673,000
-10,620,000
-5,156,000
-12,006,000
-9,370,000
821,000
-790,000
-3,526,000
-5,839,000
-10,949,000
-4,833,000
-5,908,000
-2,272,000
-702,000
-6,348,000
-1,328,000
-4,854,000
-2,768,000
-1,022,000
-1,431,000
4,614,000
-5,875,000
-9,414,000
-17,663,000
-22,741,000
-24,738,000
-36,426,000
-21,778,000
-14,143,000
-18,329,000
8,611,000
-7,010,000
-15,961,000
-1,306,000
-21,568,000
-23,230,000
-40,947,000
-55,832,000
-231,874,000
-239,551,000
-216,889,000
-82,661,000
112,557,000
139,961,000
132,245,000
26,635,000
54,928,000
44,505,000
46,907,000
41,192,000
-114,000
6,702,000
18,962,000
14,863,000
12,101,000
9,014,000
-6,248,000
-6,813,000
-1,120,000
-6,211,000
6,955,000
-42,000
13,134,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.